{"schema_version":"1.0.0","id":"se:pmod-2024-4","jurisdiction":"se","lang":"sv","judgment_class":"D","text_included":false,"text_note":"Full text is read from the official source. This record carries structured metadata and the text fingerprint.","word_count":11914,"cites":["C-121/17","C-650/17","C-493/12"],"sha256":"9dbe43bc7e6b7b0501211d0e65f271d6f3a153eb36ed380d354c39d94a2821fa","source_url":"https://rattspraxis.etjanst.domstol.se/api/v1/publiceringar/debae354-c397-4a91-9dc1-749dd2cf0571","fetched_at":"2026-10-23T02:10:01.771+00:00","full_text_view":"https://legal.exploreworldai.com/api/public/v1/full-judgment/pmod-2024-4?view=full","risk_graph":"https://legal.exploreworldai.com/api/public/v1/risk?id=se:pmod-2024-4","relations_graph":"https://legal.exploreworldai.com/api/public/v1/relations?id=se:pmod-2024-4","agent":"https://legal.exploreworldai.com/api/public/v1/se-praxis/agent?id=se:pmod-2024-4","ref":"PMÖD 2024:4","court":"Patent- och marknadsöverdomstolen","decided":"2024-05-30","provisions":["Artikel 3 a i Europaparlamentets och rådets förordning (EG) nr 469/2009 av den 6 maj 2009 om tilläggsskydd för läkemedel"],"source":"NovaCopilot"}